<DOC>
	<DOCNO>NCT00938522</DOCNO>
	<brief_summary>The purpose study investigate effect cilostazol loading plan PCI major adverse cardiac cerebrovascular event patient coronary artery disease .</brief_summary>
	<brief_title>Efficacy Study Cilostazol Loading Elective Percutaneous Coronary Intervention</brief_title>
	<detailed_description />
	<mesh_term>Cilostazol</mesh_term>
	<criteria>Patients undergo elective PCI Presence coronary lesion amenable stent Cardiogenic shock Urgent PCI Hypersensitivity aspirin , clopidogrel , cilostazol LVEF &lt; 30 % congestive heart failure Bleeding diathesis leukocyte count &lt; 3,000/mm3 and/or platelet count &lt; 100,000/mm3 aspartate aminotransferase alanine aminotransferase &gt; 3 time upper normal ; serum creatinine &gt; 2.0 mg/dl noncardiac disease life expectancy &lt; 1 year inability follow protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Cilostazol loading</keyword>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
</DOC>